
TOKYO -- Japanese chemical and materials maker AGC said Thursday it has teamed up with an Osaka University-affiliated biotechnology company to help produce a coronavirus vaccine that offers a great mass-manufacturing advantage.
Collaboration led by biotech venture hopes to have trials out this summer
TOKYO -- Japanese chemical and materials maker AGC said Thursday it has teamed up with an Osaka University-affiliated biotechnology company to help produce a coronavirus vaccine that offers a great mass-manufacturing advantage.
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.